Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study
Clinical trial NCT06649422 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06649422
- Sponsor
- Shandong University
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-01
- Primary completion
- 2025-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.